Table 5 Endpoints. NA: It was not possible to find upper confidence levels for median overall survival due to too few deaths during the study period
Endpoints | All patients N = 228 | Intervention arm N = 119 | Control arm N = 109 | P-value |
|---|---|---|---|---|
Hospital admissions, n (%) | 84 (37) | 49 (41) | 35 (32) | 0.17 |
Completion of treatment, n (%) | 122 (56) | 61 (51) | 61 (56) | 0.51 |
Overall survival, (months median, 95% CI) | 22.3 (20.4-NA) | 22.3 (17.0-NA) | 23.1 (17.7-NA) | 0.8 |
Dose reductions, n (%) | 41 (18) | 23 (19) | 18 (17) | 0.61 |